Clinical Trial Update: OLIF25™ /OLIF51™ Study

View source ↗

Summary

The OLIF25 and OLIF51 study sponsored by Medtronic Spinal and Biologics has been terminated, involving degenerative disc disease and scoliosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Disc Disease
• Scoliosis

Snippet

Sponsor: Medtronic Spinal and Biologics | Conditions: Degenerative Disc Disease, Scoliosis | Status: TERMINATED